 | • レポートコード：MRC2102QY9667 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の神経学的バイオマーカー市場について種類別（プロテオミクス、ゲノミクス、イメージング、バイオインフォマティクス、その他）、用途別（診断、創薬、個別化医療、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・神経学的バイオマーカー市場の概要 ・世界の主要地域別神経学的バイオマーカー市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の神経学的バイオマーカー市場規模2015-2026：種類別（プロテオミクス、ゲノミクス、イメージング、バイオインフォマティクス、その他） ・世界の神経学的バイオマーカー市場規模2015-2026：用途別（診断、創薬、個別化医療、その他） ・神経学的バイオマーカーの米国市場規模2015-2020 ・神経学的バイオマーカーのヨーロッパ市場規模2015-2020 ・神経学的バイオマーカーの中国市場規模2015-2020 ・神経学的バイオマーカーの日本市場規模2015-2020 ・神経学的バイオマーカーの東南アジア市場規模2015-2020 ・神経学的バイオマーカーのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・神経学的バイオマーカーの製造コスト分析 ・販売チャネル、流通業者、顧客 ・神経学的バイオマーカーの市場動向・機会・課題 ・調査の結論 |
A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
The classification of Neurological Biomarkers includes Proteomics, Genomics, Imaging, Bioinformatics and others, and the proportion of Proteomics in 2017 is about 31%.
Market Analysis and Insights: Global Neurological Biomarkers Market
The global Neurological Biomarkers market size is projected to reach US$ 10910 million by 2026, from US$ 6296.1 million in 2020, at a CAGR of 9.6% during 2021-2026.
Global Neurological Biomarkers Scope and Market Size
The global Neurological Biomarkers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neurological Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Neurological Biomarkers market is segmented into
Proteomics
Genomics
Imaging
Bioinformatics
Others
Segment by Application, the Neurological Biomarkers market is segmented into
Diagnostics
Drug Discovery
Personalized Medicine
Others
The Neurological Biomarkers market is analysed and market size information is provided by regions (countries). Segment by Application, the Neurological Biomarkers market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Neurological Biomarkers Market Share Analysis
Neurological Biomarkers market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neurological Biomarkers business, the date to enter into the Neurological Biomarkers market, Neurological Biomarkers product introduction, recent developments, etc.
The major vendors covered:
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
1 Neurological Biomarkers Market Overview
1.1 Neurological Biomarkers Product Scope
1.2 Neurological Biomarkers Segment by Type
1.2.1 Global Neurological Biomarkers Sales by Type (2020-2026)
1.2.2 Proteomics
1.2.3 Genomics
1.2.4 Imaging
1.2.5 Bioinformatics
1.2.6 Others
1.3 Neurological Biomarkers Segment by Application
1.3.1 Global Neurological Biomarkers Sales Comparison by Application (2020-2026)
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Neurological Biomarkers Market Estimates and Forecasts (2015-2026)
1.4.1 Global Neurological Biomarkers Sales Growth Rate (2015-2026)
1.4.2 Global Neurological Biomarkers Revenue and Growth Rate (2015-2026)
1.4.3 Global Neurological Biomarkers Price Trends (2015-2026)
2 Neurological Biomarkers Estimate and Forecast by Region
2.1 Global Neurological Biomarkers Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Neurological Biomarkers Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Neurological Biomarkers Sales Market Share by Region (2015-2020)
2.2.2 Global Neurological Biomarkers Revenue Market Share by Region (2015-2020)
2.3 Global Neurological Biomarkers Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Neurological Biomarkers Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Neurological Biomarkers Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Neurological Biomarkers Estimates and Projections (2015-2026)
2.4.2 Europe Neurological Biomarkers Estimates and Projections (2015-2026)
2.4.3 China Neurological Biomarkers Estimates and Projections (2015-2026)
2.4.4 Japan Neurological Biomarkers Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Neurological Biomarkers Estimates and Projections (2015-2026)
2.4.6 India Neurological Biomarkers Estimates and Projections (2015-2026)
3 Global Neurological Biomarkers Competition Landscape by Players
3.1 Global Top Neurological Biomarkers Players by Sales (2015-2020)
3.2 Global Top Neurological Biomarkers Players by Revenue (2015-2020)
3.3 Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurological Biomarkers as of 2019)
3.4 Global Neurological Biomarkers Average Price by Company (2015-2020)
3.5 Manufacturers Neurological Biomarkers Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Neurological Biomarkers Players (Opinion Leaders)
4 Global Neurological Biomarkers Market Size by Type
4.1 Global Neurological Biomarkers Historic Market Review by Type (2015-2020)
4.1.1 Global Neurological Biomarkers Sales Market Share by Type (2015-2020)
4.1.2 Global Neurological Biomarkers Revenue Market Share by Type (2015-2020)
4.1.3 Global Neurological Biomarkers Price by Type (2015-2020)
4.2 Global Neurological Biomarkers Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Neurological Biomarkers Sales Forecast by Type (2021-2026)
4.2.2 Global Neurological Biomarkers Revenue Forecast by Type (2021-2026)
4.2.3 Global Neurological Biomarkers Price Forecast by Type (2021-2026)
5 Global Neurological Biomarkers Market Size by Application
5.1 Global Neurological Biomarkers Historic Market Review by Application (2015-2020)
5.1.1 Global Neurological Biomarkers Sales Market Share by Application (2015-2020)
5.1.2 Global Neurological Biomarkers Revenue Market Share by Application (2015-2020)
5.1.3 Global Neurological Biomarkers Price by Application (2015-2020)
5.2 Global Neurological Biomarkers Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Neurological Biomarkers Sales Forecast by Application (2021-2026)
5.2.2 Global Neurological Biomarkers Revenue Forecast by Application (2021-2026)
5.2.3 Global Neurological Biomarkers Price Forecast by Application (2021-2026)
6 United States Neurological Biomarkers Market Facts & Figures
6.1 United States Neurological Biomarkers Sales Market Share by Company (2015-2020)
6.2 United States Neurological Biomarkers Sales Market Share by Type (2015-2020)
6.3 United States Neurological Biomarkers Sales Market Share by Application (2015-2020)
7 Europe Neurological Biomarkers Market Facts & Figures
7.1 Europe Neurological Biomarkers Sales Market Share by Company (2015-2020)
7.2 Europe Neurological Biomarkers Sales Market Share by Type (2015-2020)
7.3 Europe Neurological Biomarkers Sales Market Share by Application (2015-2020)
8 China Neurological Biomarkers Market Facts & Figures
8.1 China Neurological Biomarkers Sales Market Share by Company (2015-2020)
8.2 China Neurological Biomarkers Sales Market Share by Type (2015-2020)
8.3 China Neurological Biomarkers Sales Market Share by Application (2015-2020)
9 Japan Neurological Biomarkers Market Facts & Figures
9.1 Japan Neurological Biomarkers Sales Market Share by Company (3015-3030)
9.2 Japan Neurological Biomarkers Sales Market Share by Type (2015-2020)
9.3 Japan Neurological Biomarkers Sales Market Share by Application (2015-2020)
10 Southeast Asia Neurological Biomarkers Market Facts & Figures
10.1 Southeast Asia Neurological Biomarkers Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Neurological Biomarkers Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Neurological Biomarkers Sales Market Share by Application (2015-2020)
11 India Neurological Biomarkers Market Facts & Figures
11.1 India Neurological Biomarkers Sales Market Share by Company (2015-2020)
11.2 India Neurological Biomarkers Sales Market Share by Type (2015-2020)
11.3 India Neurological Biomarkers Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Neurological Biomarkers Business
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Corporation Information
12.1.2 Thermo Fisher Scientific Business Overview
12.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Thermo Fisher Scientific Neurological Biomarkers Products Offered
12.1.5 Thermo Fisher Scientific Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Neurological Biomarkers Products Offered
12.2.5 Merck Recent Development
12.3 Quest Diagnostics
12.3.1 Quest Diagnostics Corporation Information
12.3.2 Quest Diagnostics Business Overview
12.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Quest Diagnostics Neurological Biomarkers Products Offered
12.3.5 Quest Diagnostics Recent Development
12.4 Abbott
12.4.1 Abbott Corporation Information
12.4.2 Abbott Business Overview
12.4.3 Abbott Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Abbott Neurological Biomarkers Products Offered
12.4.5 Abbott Recent Development
12.5 Roche
12.5.1 Roche Corporation Information
12.5.2 Roche Business Overview
12.5.3 Roche Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Roche Neurological Biomarkers Products Offered
12.5.5 Roche Recent Development
12.6 Illumina
12.6.1 Illumina Corporation Information
12.6.2 Illumina Business Overview
12.6.3 Illumina Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Illumina Neurological Biomarkers Products Offered
12.6.5 Illumina Recent Development
12.7 Bio-Rad Laboratories
12.7.1 Bio-Rad Laboratories Corporation Information
12.7.2 Bio-Rad Laboratories Business Overview
12.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bio-Rad Laboratories Neurological Biomarkers Products Offered
12.7.5 Bio-Rad Laboratories Recent Development
12.8 QIAGEN
12.8.1 QIAGEN Corporation Information
12.8.2 QIAGEN Business Overview
12.8.3 QIAGEN Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.8.4 QIAGEN Neurological Biomarkers Products Offered
12.8.5 QIAGEN Recent Development
12.9 Myriad RBM
12.9.1 Myriad RBM Corporation Information
12.9.2 Myriad RBM Business Overview
12.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Myriad RBM Neurological Biomarkers Products Offered
12.9.5 Myriad RBM Recent Development
12.10 Cisbio Bioassays
12.10.1 Cisbio Bioassays Corporation Information
12.10.2 Cisbio Bioassays Business Overview
12.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Cisbio Bioassays Neurological Biomarkers Products Offered
12.10.5 Cisbio Bioassays Recent Development
12.11 Athena Diagnostics
12.11.1 Athena Diagnostics Corporation Information
12.11.2 Athena Diagnostics Business Overview
12.11.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Athena Diagnostics Neurological Biomarkers Products Offered
12.11.5 Athena Diagnostics Recent Development
12.12 BGI
12.12.1 BGI Corporation Information
12.12.2 BGI Business Overview
12.12.3 BGI Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.12.4 BGI Neurological Biomarkers Products Offered
12.12.5 BGI Recent Development
12.13 Wuxi APP
12.13.1 Wuxi APP Corporation Information
12.13.2 Wuxi APP Business Overview
12.13.3 Wuxi APP Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Wuxi APP Neurological Biomarkers Products Offered
12.13.5 Wuxi APP Recent Development
12.14 Aepodia
12.14.1 Aepodia Corporation Information
12.14.2 Aepodia Business Overview
12.14.3 Aepodia Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Aepodia Neurological Biomarkers Products Offered
12.14.5 Aepodia Recent Development
12.15 Proteome Sciences
12.15.1 Proteome Sciences Corporation Information
12.15.2 Proteome Sciences Business Overview
12.15.3 Proteome Sciences Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Proteome Sciences Neurological Biomarkers Products Offered
12.15.5 Proteome Sciences Recent Development
12.16 Genewiz
12.16.1 Genewiz Corporation Information
12.16.2 Genewiz Business Overview
12.16.3 Genewiz Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Genewiz Neurological Biomarkers Products Offered
12.16.5 Genewiz Recent Development
13 Neurological Biomarkers Manufacturing Cost Analysis
13.1 Neurological Biomarkers Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Neurological Biomarkers
13.4 Neurological Biomarkers Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Neurological Biomarkers Distributors List
14.3 Neurological Biomarkers Customers
15 Market Dynamics
15.1 Neurological Biomarkers Market Trends
15.2 Neurological Biomarkers Opportunities and Drivers
15.3 Neurological Biomarkers Market Challenges
15.4 Neurological Biomarkers Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Neurological Biomarkers Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Neurological Biomarkers Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Neurological Biomarkers Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Neurological Biomarkers Sales (K Units) by Region (2015-2020)
Table 5. Global Neurological Biomarkers Sales Market Share by Region (2015-2020)
Table 6. Global Neurological Biomarkers Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Neurological Biomarkers Revenue Share by Region (2015-2020)
Table 8. Global Neurological Biomarkers Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Neurological Biomarkers Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Neurological Biomarkers Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Neurological Biomarkers Revenue Share Forecast by Region (2021-2026)
Table 12. Global Neurological Biomarkers (K Units) of Key Companies (2015-2020)
Table 13. Global Neurological Biomarkers Sales Share by Company (2015-2020)
Table 14. Global Neurological Biomarkers Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Neurological Biomarkers Revenue Share by Company (2015-2020)
Table 16. Global Neurological Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurological Biomarkers as of 2019)
Table 17. Global Neurological Biomarkers Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Neurological Biomarkers Manufacturing Sites and Area Served
Table 19. Manufacturers Neurological Biomarkers Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Neurological Biomarkers Players
Table 22. Global Neurological Biomarkers Sales (K Units) by Type (2015-2020)
Table 23. Global Neurological Biomarkers Sales Share by Type (2015-2020)
Table 24. Global Neurological Biomarkers Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Neurological Biomarkers Price (K Units) by Type (2015-2020)
Table 26. Global Neurological Biomarkers Sales Share by Type (2021-2026)
Table 27. Global Neurological Biomarkers Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Neurological Biomarkers Revenue Share by Type (2021-2026)
Table 29. Global Neurological Biomarkers Price (K Units) by Type (2021-2026)
Table 30. Global Neurological Biomarkers Sales (K Units) by Application (2015-2020)
Table 31. Global Neurological Biomarkers Sales Share by Application (2015-2020)
Table 32. Global Neurological Biomarkers Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Neurological Biomarkers Price (K Units) by Application (2015-2020)
Table 34. Global Neurological Biomarkers Sales (K Units) by Application (2021-2026)
Table 35. Global Neurological Biomarkers Sales Share by Application (2021-2026)
Table 36. Global Neurological Biomarkers Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Neurological Biomarkers Revenue Share by Application (2021-2026)
Table 38. Global Neurological Biomarkers Price (K Units) by Application (2021-2026)
Table 39. United States Neurological Biomarkers Sales (K Units) by Company (2015-2020)
Table 40. United States Neurological Biomarkers Sales Market Share by Company (2015-2020)
Table 41. United States Neurological Biomarkers Sales (K Units) by Type (2015-2020)
Table 42. United States Neurological Biomarkers Sales Market Share by Type (2015-2020)
Table 43. United States Neurological Biomarkers Sales (K Units) by Application (2015-2020)
Table 44. United States Neurological Biomarkers Sales Market Share by Application (2015-2020)
Table 45. Europe Neurological Biomarkers Sales (K Units) by Company (2015-2020)
Table 46. Europe Neurological Biomarkers Sales Market Share by Company (2015-2020)
Table 47. Europe Neurological Biomarkers Sales (K Units) by Type (2015-2020)
Table 48. Europe Neurological Biomarkers Sales Market Share by Type (2015-2020)
Table 49. Europe Neurological Biomarkers Sales (K Units) by Application (2015-2020)
Table 50. Europe Neurological Biomarkers Sales Market Share by Type (2015-2020)
Table 51. China Neurological Biomarkers Sales (K Units) by Company (2015-2020)
Table 52. China Neurological Biomarkers Sales Market Share by Company (2015-2020)
Table 53. China Neurological Biomarkers Sales (K Units) by Type (2015-2020)
Table 54. China Neurological Biomarkers Sales Market Share by Type (2015-2020)
Table 55. China Neurological Biomarkers Sales (K Units) by Application (2015-2020)
Table 56. China Neurological Biomarkers Sales Market Share by Application (2015-2020)
Table 57. Japan Neurological Biomarkers Sales (K Units) by Company (2015-2020)
Table 58. Japan Neurological Biomarkers Sales Market Share by Company (2015-2020)
Table 59. Japan Neurological Biomarkers Sales (K Units) by Type (2015-2020)
Table 60. Japan Neurological Biomarkers Sales Market Share by Type (2015-2020)
Table 61. Japan Neurological Biomarkers Sales (K Units) by Application (2015-2020)
Table 62. Japan Neurological Biomarkers Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Neurological Biomarkers Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Neurological Biomarkers Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Neurological Biomarkers Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Neurological Biomarkers Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Neurological Biomarkers Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Neurological Biomarkers Sales Market Share by Application (2015-2020)
Table 69. India Neurological Biomarkers Sales (K Units) by Company (2015-2020)
Table 70. India Neurological Biomarkers Sales Market Share by Company (2015-2020)
Table 71. India Neurological Biomarkers Sales (K Units) by Type (2015-2020)
Table 72. India Neurological Biomarkers Sales Market Share by Type (2015-2020)
Table 73. India Neurological Biomarkers Sales (K Units) by Application (2015-2020)
Table 74. India Neurological Biomarkers Sales Market Share by Application (2015-2020)
Table 75. Thermo Fisher Scientific Corporation Information
Table 76. Thermo Fisher Scientific Description and Business Overview
Table 77. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Thermo Fisher Scientific Neurological Biomarkers Product
Table 79. Thermo Fisher Scientific Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Merck Neurological Biomarkers Product
Table 84. Merck Recent Development
Table 85. Quest Diagnostics Corporation Information
Table 86. Quest Diagnostics Description and Business Overview
Table 87. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Quest Diagnostics Neurological Biomarkers Product
Table 89. Quest Diagnostics Recent Development
Table 90. Abbott Corporation Information
Table 91. Abbott Description and Business Overview
Table 92. Abbott Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Abbott Neurological Biomarkers Product
Table 94. Abbott Recent Development
Table 95. Roche Corporation Information
Table 96. Roche Description and Business Overview
Table 97. Roche Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Roche Neurological Biomarkers Product
Table 99. Roche Recent Development
Table 100. Illumina Corporation Information
Table 101. Illumina Description and Business Overview
Table 102. Illumina Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Illumina Neurological Biomarkers Product
Table 104. Illumina Recent Development
Table 105. Bio-Rad Laboratories Corporation Information
Table 106. Bio-Rad Laboratories Description and Business Overview
Table 107. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Bio-Rad Laboratories Neurological Biomarkers Product
Table 109. Bio-Rad Laboratories Recent Development
Table 110. QIAGEN Corporation Information
Table 111. QIAGEN Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. QIAGEN Description and Business Overview
Table 113. QIAGEN Neurological Biomarkers Product
Table 114. QIAGEN Recent Development
Table 115. Myriad RBM Corporation Information
Table 116. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Myriad RBM Description and Business Overview
Table 118. Myriad RBM Neurological Biomarkers Product
Table 119. Myriad RBM Recent Development
Table 120. Cisbio Bioassays Corporation Information
Table 121. Cisbio Bioassays Description and Business Overview
Table 122. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Cisbio Bioassays Neurological Biomarkers Product
Table 124. Cisbio Bioassays Recent Development
Table 125. Athena Diagnostics Corporation Information
Table 126. Athena Diagnostics Description and Business Overview
Table 127. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Athena Diagnostics Neurological Biomarkers Product
Table 129. Athena Diagnostics Recent Development
Table 130. BGI Corporation Information
Table 131. BGI Description and Business Overview
Table 132. BGI Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. BGI Neurological Biomarkers Product
Table 134. BGI Recent Development
Table 135. Wuxi APP Corporation Information
Table 136. Wuxi APP Description and Business Overview
Table 137. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Wuxi APP Neurological Biomarkers Product
Table 139. Wuxi APP Recent Development
Table 140. Aepodia Corporation Information
Table 141. Aepodia Description and Business Overview
Table 142. Aepodia Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Aepodia Neurological Biomarkers Product
Table 144. Aepodia Recent Development
Table 145. Proteome Sciences Corporation Information
Table 146. Proteome Sciences Description and Business Overview
Table 147. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Proteome Sciences Neurological Biomarkers Product
Table 149. Proteome Sciences Recent Development
Table 150. Genewiz Corporation Information
Table 151. Genewiz Description and Business Overview
Table 152. Genewiz Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Genewiz Neurological Biomarkers Product
Table 154. Genewiz Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Neurological Biomarkers Distributors List
Table 158. Neurological Biomarkers Customers List
Table 159. Neurological Biomarkers Market Key Trends
Table 160. Neurological Biomarkers Key Opportunities and Drivers
Table 161. Neurological Biomarkers Market Challenges
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurological Biomarkers Product Picture
Figure 2. Global Neurological Biomarkers Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Neurological Biomarkers Market Share by Application in 2020 & 2026
Figure 6. Diagnostics Examples
Figure 7. Drug Discovery Examples
Figure 8. Personalized Medicine Examples
Figure 9. Others Examples
Figure 10. Global Neurological Biomarkers Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Neurological Biomarkers Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Neurological Biomarkers Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Neurological Biomarkers Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Neurological Biomarkers Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Neurological Biomarkers Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Neurological Biomarkers Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Neurological Biomarkers Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Neurological Biomarkers Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Neurological Biomarkers Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Neurological Biomarkers Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Neurological Biomarkers Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Neurological Biomarkers Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Neurological Biomarkers Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Neurological Biomarkers Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Neurological Biomarkers Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Neurological Biomarkers Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Neurological Biomarkers Players Market Share by Revenue in Neurological Biomarkers 2015 & 2019
Figure 28. Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Neurological Biomarkers Revenue Share by Type (2015-2020)
Figure 30. Global Neurological Biomarkers Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Neurological Biomarkers Revenue Share by Application (2015-2020)
Figure 32. Global Neurological Biomarkers Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Neurological Biomarkers Sales Market Share by Type in 2019
Figure 34. United States Neurological Biomarkers Sales Market Share by Type in 2019
Figure 35. Europe Neurological Biomarkers Sales Market Share by Company in 2019
Figure 36. Europe Neurological Biomarkers Sales Market Share by Type in 2019
Figure 37. Europe Neurological Biomarkers Sales Market Share by Application in 2019
Figure 38. China Neurological Biomarkers Sales Market Share by Company in 2019
Figure 39. China Neurological Biomarkers Sales Market Share by Type in 2019
Figure 40. China Neurological Biomarkers Sales Market Share by Application in 2019
Figure 41. Japan Neurological Biomarkers Sales Market Share by Company in 2019
Figure 42. Japan Neurological Biomarkers Sales Market Share by Type in 2019
Figure 43. Japan Neurological Biomarkers Sales Market Share by Application in 2019
Figure 44. Southeast Asia Neurological Biomarkers Sales Market Share by Company in 2019
Figure 45. Southeast Asia Neurological Biomarkers Sales Market Share by Type in 2019
Figure 46. Southeast Asia Neurological Biomarkers Sales Market Share by Application in 2019
Figure 47. India Neurological Biomarkers Sales Market Share by Company in 2019
Figure 48. India Neurological Biomarkers Sales Market Share by Type in 2019
Figure 49. India Neurological Biomarkers Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Neurological Biomarkers
Figure 52. Manufacturing Process Analysis of Neurological Biomarkers
Figure 53. Neurological Biomarkers Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
バイオマーカー商品化の世界市場レポート2020 Market Analysis and Insights: Global Commercializing Biomarkers Market The global Commercializing Biomarkers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Commercializing Biomarkers Scope and Market Size The global Co…- 神経学的診断機器の世界市場レポート2020 Market Analysis and Insights: Global Neurological Diagnostic Equipment Market The global Neurological Diagnostic Equipment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Neurological Diagnostic Equipment Scope and Mark…
- 糖衣錠の世界市場レポート2020 Sugar Coated Tablets are coated with a colored or an uncolored sugar layer. The coating is water soluble and quickly dissolves after swallowing. The sugar-coating protects the encapsulated drug from the environment and provides a barrier to objectionable tablet taste or odor. There are mainly two ty…
- 癒着バリアの世界市場レポート2020 An adhesion barrier is an artificial substance, usually a gel or a film, that is placed on an organ over the internal incision created during surgery. The barrier prevents the organ from coming into contact with other organs or the interior of the cavity and forming scar tissue, called adhesions. Ab…
- D-AP5の世界市場レポート2020 Market Analysis and Insights: Global D-AP5 Market The global D-AP5 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global D-AP5 Scope and Market Size The global D-AP5 market is segmented by company, region (country), by Type, …